On July 31, 2025, the Trump administration released “Winning the Race: America’s AI Action Plan.” CSET has broken down the Action Plan, focusing on specific government deliverables. Our Provision and Timeline tracker breaks down which agencies are responsible for implementing recommendations and the types of actions they should take.

This blog examines 18 AI-related laws that California enacted in 2024, 8 of which are explored in more detail in an accompanying CSET Emerging Technology Observatory (ETO) blog. This blog also chronicles California’s history of regulating AI and other emerging technologies and highlights several AI bills that have moved through the California legislature in 2025.

To protect Europeans from the risks posed by artificial intelligence, the EU passed its AI Act last year. This month, the EU released a Code of Practice to help providers of general purpose AI comply with the AI Act. This blog reviews the measures set out in the new Code’s safety and security chapter, assesses how they compare to existing practices, and what the Code’s global impact might be.

Effectively evaluating AI models is more crucial than ever. But how do AI evaluations actually work? Our explainer lays out the different fundamental types of AI safety evaluations alongside their respective strengths and limitations.

Opposing narratives around AI for biotechnology raise the question: how are biotech researchers actually using AI in published research? CSET’s Steph Batalis, Catherine Aiken, and James Dunham explored this question by leveraging CSET’s merged academic corpus, enriched publication metadata, and research clusters.

Artificial intelligence is becoming more integrated into the sciences. One of the scientific fields experiencing this is computational biology, which uses computer modeling to understand biological mechanisms and systems. This blog post provides an understanding of important research trends in these subject areas, and how advancements in AI can improve the speed and efficiency of computational biology to improve human health and well-being.

The European Union's Artificial Intelligence Act has officially come into force today after more than five years of legislative processes and negotiations. While marking a significant milestone, it also initiates a prolonged phase of implementation, refinement, and enforcement. This blog post outlines key aspects of the regulation, such as rules for general-purpose AI and governance structures, and provides insights into its timeline and future expectations.

Now that the first set of milestones has passed for the Biden administration’s October 2023 executive order on artificial intelligence, where do things stand for biotech? This blog post gives an overview of the most recent action items, with a recap of expert commentary from CSET’s June 2024 Webinar on the AIxBio Policy Landscape.

The October 30, 2023, White House executive order on artificial intelligence requires companies developing the most advanced AI models to report safety testing results to the federal government. CSET Horizon Junior Fellow Thomas Woodside writes that these requirements are a good first step towards managing uncertain risks and Congress should consider codifying them into law.

As the U.S. government considers banning genomics companies from China in the Biosecure Act, it opens a broader question of how the U.S. and other market economies should deal with China’s national champions. This blog post provides an overview of BGI and how China’s industrial policy impacts technology development.